
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
Pheton Holdings Ltd Class A Ordinary Shares (PTHL)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: PTHL (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -71.35% | Avg. Invested days 87 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 55.68M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 1.32 - 22.34 | Updated Date 04/17/2025 |
52 Weeks Range 1.32 - 22.34 | Updated Date 04/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.03 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -77.36% | Operating Margin (TTM) -149.31% |
Management Effectiveness
Return on Assets (TTM) -23.42% | Return on Equity (TTM) -188.15% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 37837295 | Price to Sales(TTM) 97.29 |
Enterprise Value 37837295 | Price to Sales(TTM) 97.29 | ||
Enterprise Value to Revenue 66.12 | Enterprise Value to EBITDA - | Shares Outstanding 6582000 | Shares Floating 3183120 |
Shares Outstanding 6582000 | Shares Floating 3183120 | ||
Percent Insiders 44.76 | Percent Institutions 0.24 |
Upturn AI SWOT
Pheton Holdings Ltd Class A Ordinary Shares
Company Overview
History and Background
There is no publicly traded US stock for 'Pheton Holdings Ltd Class A Ordinary Shares'. This response is a placeholder and illustrates the required JSON format. A real company would need to be specified for accurate data.
Core Business Areas
- Segment Name 1: N/A due to lack of a real company to look into
- Segment Name 2: N/A due to lack of a real company to look into
Leadership and Structure
N/A due to lack of a real company to look into
Top Products and Market Share
Key Offerings
- Product Name 1: N/A due to lack of a real company to look into
- Product Name 2: N/A due to lack of a real company to look into
Market Dynamics
Industry Overview
N/A due to lack of a real company to look into
Positioning
N/A due to lack of a real company to look into
Total Addressable Market (TAM)
N/A due to lack of a real company to look into
Upturn SWOT Analysis
Strengths
- N/A
- N/A
- N/A
Weaknesses
- N/A
- N/A
- N/A
Opportunities
- N/A
- N/A
- N/A
Threats
- N/A
- N/A
- N/A
Competitors and Market Share
Key Competitors
Competitive Landscape
N/A
Growth Trajectory and Initiatives
Historical Growth: N/A due to lack of a real company to look into
Future Projections: N/A due to lack of a real company to look into
Recent Initiatives: N/A due to lack of a real company to look into
Summary
Due to the non-existence of a publicly traded US stock with the name provided, it's impossible to provide a summary. A specific company would be required for this analysis. The provided output is merely a placeholder.
Peer Comparison
Sources and Disclaimers
Data Sources:
- N/A
Disclaimers:
The information provided is based on the absence of available data for the specified company. This is a placeholder response.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Pheton Holdings Ltd Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-09-05 | CEO & Chairman of the Board Mr. Jianfei Zhang | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10 | Website https://www.ftzy.com.cn |
Full time employees 10 | Website https://www.ftzy.com.cn |
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.